Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             133 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aims & Scope/Editorial Board 2017
 9 C p. IFC-
1 p.
 artikel
2 Author Index 2017
 9 C p. I-V
nvt p.
 artikel
3 General Information ISSHP European Congress 06–09 September 2017 2017
 9 C p. 1-
1 p.
 artikel
4 IA 6 Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN-Trial) Ekkehard Schleußner, Tanja Groten,
 2017
 9 C p. 8-
1 p.
 artikel
5 IA 9 Prediction of late onset IUGR Triunfo, Stefania
 2017
 9 C p. 8-
1 p.
 artikel
6 KL 16 Abnormal glucose signaling in trophoblast biology Bettocchi, Stefano
 2017
 9 C p. 6-
1 p.
 artikel
7 KL 10 Animal models for gestational hypertension Delles, Christian
 2017
 9 C p. 5-
1 p.
 artikel
8 KL 3 Maternal long-term outcome after preeclampsia Staff, Anne Cathrine
 2017
 9 C p. 4-
1 p.
 artikel
9 KL 1 Modern management of hypertension in pregnancy – More than just antihypertensive therapy and delivery Mohaupt, Markus G.
 2017
 9 C p. 4-
1 p.
 artikel
10 KL 38 Novel therapeutic approaches to placental insufficiency Ganzevoort, Wessel
 2017
 9 C p. 7-
1 p.
 artikel
11 KL 37 Statins for prevention of pre-eclampsia Williams, David
 2017
 9 C p. 7-
1 p.
 artikel
12 KL 14 Targeted therapies in preeclampsia Thadhani, Ravi
 2017
 9 C p. 5-6
2 p.
 artikel
13 KL 15 Treatment of very preterm preeclampsia via heparin-mediated extracorporeal LDL-precipitation (H.E.L.P) apheresis results in favorable fetal outcome and weight gain without lowering soluble FMS-like tyrosine kinase-1 (sFlt-1): The Freiburg preeclampsia HELP-apheresis study Winkler, Karl
 2017
 9 C p. 6-
1 p.
 artikel
14 KL 5 Trophoblast-immune cell communication via microRNA transported in extracellular vesicles Chaiwangyen, Wittaya
 2017
 9 C p. 5-
1 p.
 artikel
15 KL 39 Update on genetics in preeclampsia Laivuori, Hannele
 2017
 9 C p. 7-
1 p.
 artikel
16 KL 30 Vascular mediators leading to hypertension in pregnancy den Meiracker van, Anton
 2017
 9 C p. 7-
1 p.
 artikel
17 OP 22 Abnormal mid-trimester cardiac strain in African American patients with chronic hypertension predates superimposed preeclampsia – Preeclampsia a possible cardiovascular disease Ramadan, Hadi
 2017
 9 C p. 18-19
2 p.
 artikel
18 OP 21 Absence of corpus luteum impairs maternal endothelial health in early pregnancy – A contributor to the increased risk for hypertensive disease after assisted reproduction? Versen-Höynck, Frauke von
 2017
 9 C p. 18-
1 p.
 artikel
19 OP 49 Air pollution effects on preeclampsia-effects by size of particles and by sources Malmqvist, Ebba
 2017
 9 C p. 30-
1 p.
 artikel
20 OP 14 Angiogenic factors in pregnancies complicated by rheumatoid arthritis Laue, Jessica
 2017
 9 C p. 15-
1 p.
 artikel
21 OP 16 An intermediate sFlt-1/PlGF ratio indicates an increased risk for adverse pregnancy outcome Hoffmann, Janine
 2017
 9 C p. 15-16
2 p.
 artikel
22 OP 53 Anti-hemolytic effects of α 1-microglobulin – A possible mechanism for pre-eclampsia treatment Kristiansson, Amanda
 2017
 9 C p. 32-33
2 p.
 artikel
23 OP 8 Arterial calcifications and arterial stiffness in women after preeclampsia Zoet, Gerbrand
 2017
 9 C p. 12-
1 p.
 artikel
24 OP 3 Assessment of the added value of early pregnancy 24-h ambulatory blood pressure monitoring for the prediction of pre-eclampsia in women with chronic hypertension Shawkat, Emma
 2017
 9 C p. 10-
1 p.
 artikel
25 OP 55 Associations between fetal HLA-G genotype and birth and placenta weight in pregnancies complicated by preeclampsia and in uncomplicated pregnancies possible implications for HLA diversity Emmery, Johanne
 2017
 9 C p. 34-35
2 p.
 artikel
26 OP 39 Cerebral osmolytes and osmolality in pregnancy and preeclampsia Nelander, Maria
 2017
 9 C p. 26-27
2 p.
 artikel
27 OP 1 Comparing the pregnancy outcome in nuliparas both with and without microalbuminuria at the end of the second trimester of pregnancy Kashanian, Maryam
 2017
 9 C p. 9-
1 p.
 artikel
28 OP 18 Comparing the sflt-1/plgf ratio with other biomarkers as a predictive test for pre-eclampsia – A clinical audit Jones, Gabriel Davis
 2017
 9 C p. 16-17
2 p.
 artikel
29 OP 33 Correlation between uterine artery Doppler parameters and sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders Premru-Srsen, Tanja
 2017
 9 C p. 24-
1 p.
 artikel
30 OP 56 Dalteparin promotes fetal and placental growth in the reduced uterine perfusion pressure model of preeclampsia Wat, Jovian
 2017
 9 C p. 35-
1 p.
 artikel
31 OP 23 Development of a mouse model lacking expression of α1-microglobulin Bergwik, Jesper
 2017
 9 C p. 19-
1 p.
 artikel
32 OP 54 Early- and late-onset preeclampsia and the tissue-specific epigenome of the placenta and newborn Herzog, Emilie M.
 2017
 9 C p. 33-34
2 p.
 artikel
33 OP 37 Familial co-aggregation of preeclampsia and cardiovascular disease Sciera, Lucca
 2017
 9 C p. 26-
1 p.
 artikel
34 OP 51 Fetal cholesterol deprivation in IUGR is caused by lower fetal synthesis rates Pecks, Ulrich
 2017
 9 C p. 32-
1 p.
 artikel
35 OP 36 Home blood pressure monitoring in pregnancy – A cost analysis Perry, Helen
 2017
 9 C p. 26-
1 p.
 artikel
36 OP 32 Hypertension self-management postpartum – The SNAP-HT pilot study – Can women do it better? Cairns, Alexandra
 2017
 9 C p. 23-24
2 p.
 artikel
37 OP 9 Hypertensive disorders of pregnancy and the risk of neurodevelopmental disorders – A systematic review and meta-analysis Maher, Gillian M.
 2017
 9 C p. 12-13
2 p.
 artikel
38 OP 35 Incidence of pre-eclampsia in the UK in 2016–17 Hendy, Eleanor
 2017
 9 C p. 25-
1 p.
 artikel
39 OP 20 Increased classical atherosclerotic risk factors in elderly women with decidual acute atherosis Moe, Kjartan
 2017
 9 C p. 17-18
2 p.
 artikel
40 OP 28 Inflammation in preeclampsia by nod-like receptor protein (nlrp)3 inflammasome activation in trophoblasts Silva, Gabriela Brettas
 2017
 9 C p. 21-
1 p.
 artikel
41 OP 40 Intrarenal angiotensinogen (AGT), potassium, glomerular endotheliosis and hypertension in pregnancy Kurlak, Lesia
 2017
 9 C p. 27-
1 p.
 artikel
42 OP 15 Investigating the role of mitochondrial dysfunction as a biomarker of pre-eclampsia Williamson, Rachel
 2017
 9 C p. 15-
1 p.
 artikel
43 OP 4 Learning to evaluate and manage antenatal blood pressure at home (LEANBH) Lim, Yoke Yin
 2017
 9 C p. 10-11
2 p.
 artikel
44 OP 10 Longitudinal assessment of cardiovascular risk factors after hypertensive disorders of pregnancy – Towards identifying a window of opportunity for screening and prevention Groenhof, Katrien
 2017
 9 C p. 13-14
2 p.
 artikel
45 OP 45 Maternal functional hemodynamics and natriuretic peptides at 22–24weeks of gestation Vårtun, Åse
 2017
 9 C p. 29-
1 p.
 artikel
46 OP 30 Maternal hemodynamics in hypertensive disorders and different feto-placental growth patterns, in pregnancy and post-partum Di Martino, Daniela
 2017
 9 C p. 22-
1 p.
 artikel
47 OP 48 Metabolic and hypertensive complications of pregnancy in women with nephrolithiasis Tangren, Jessica
 2017
 9 C p. 30-
1 p.
 artikel
48 OP 27 Methyldopa during the first trimester and pregnancy outcome – A prospective observational cohort study Hoeltzenbein, Maria
 2017
 9 C p. 21-
1 p.
 artikel
49 OP 24 Nrf2 deficiency induces placental TNF-α expression and influences the fetal growth in mice Kweider, Nisreen
 2017
 9 C p. 19-20
2 p.
 artikel
50 OP 42 Osmolality responses by TonEBP and SMIT in placental trophoblast cell lines Mohaupt, Markus
 2017
 9 C p. 28-
1 p.
 artikel
51 OP 17 Performance of commercially available placental growth factor kits in women with suspected or confirmed pre-eclampsia McCarthy, Fergus
 2017
 9 C p. 16-
1 p.
 artikel
52 OP 50 Pilot study of alterations in urinary antioxidant-associated micronutrients in women with hypertensive disorders of pregnancy Mistry, Hiten
 2017
 9 C p. 31-
1 p.
 artikel
53 OP 25 Placental differentiation and nutrient transporter expression is changed in sFlt-1 preeclampsia/IUGR mouse models Gellhaus, Alexandra
 2017
 9 C p. 20-
1 p.
 artikel
54 OP 2 Placental growth factor informed management of suspected pre-eclampsia and/or fetal growth restriction – The MAPPLE cohort study Sharp, Andrew
 2017
 9 C p. 9-10
2 p.
 artikel
55 OP 41 Postpartum levels of maternal anti-angiogenic proteins in hypertensive disorders of pregnancy Perdigao, Joana
 2017
 9 C p. 27-28
2 p.
 artikel
56 OP 5 Prediction of adverse maternal and perinatal outcomes based on target blood pressure in pregnancy hypertension Chulkov, Vasilii
 2017
 9 C p. 11-
1 p.
 artikel
57 OP 7 Preeclampsia and the risk of later renal disease Kristensen, Jonas
 2017
 9 C p. 12-
1 p.
 artikel
58 OP 26 Preeclampsia changes cardiac function and structure Kräker, Kristin
 2017
 9 C p. 20-21
2 p.
 artikel
59 OP 19 Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti Ramadan, Hadi
 2017
 9 C p. 17-
1 p.
 artikel
60 OP 57 Procoagulant extracellular vesicles impair trophoblast function by a thrombo-inflammatory pathway in preeclampsia Kohli, Shrey
 2017
 9 C p. 35-
1 p.
 artikel
61 OP 47 Risks of diabetes, fetal growth restriction and preeclampsia in women with chronic hypertension using new, more-inclusive definitions Nzelu, Diane
 2017
 9 C p. 29-30
2 p.
 artikel
62 OP 44 sFlt-1/PlGF ratio above 150 as an indicator for imminent delivery? Wertaschnigg, Dagmar
 2017
 9 C p. 28-29
2 p.
 artikel
63 OP 52 Sildenafil for the treatment of placental insufficiency – A preclinical meta-analysis on fetal growth and maternal blood pressure Paauw, Nina
 2017
 9 C p. 32-
1 p.
 artikel
64 OP 34 Systolic notch in severe preeclampsie – A Doppler marker of maternal hemodynamic dysfunction? Gonser, Markus
 2017
 9 C p. 25-
1 p.
 artikel
65 OP 6 The association between pre-eclampsia and the risk of kidney disease – A nationwide cohort study Khashan, Ali
 2017
 9 C p. 11-
1 p.
 artikel
66 OP 31 The effect of ethnicity on the performance of protein-creatinine ratio in the prediction of significant proteinuria in pregnancies at risk of or with established hypertension – An implementation audit and cost implications Bhatti, Sadia
 2017
 9 C p. 22-23
2 p.
 artikel
67 OP 29 The interaction between the maternal systemic and uteroplacental circulations in pregnancies resulting in small for gestational age newborns Khalil, Asma
 2017
 9 C p. 22-
1 p.
 artikel
68 OP 43 The predictive power of placental biomarkers regarding the postpartal course after pre-eclamptic pregnancies Hamza, Amr
 2017
 9 C p. 28-
1 p.
 artikel
69 OP 13 The tryptophan metabolite kynurenine induces vasorelaxation in systemic maternal arteries – A new target for therapeutic intervention? Worton, Stephanie
 2017
 9 C p. 14-15
2 p.
 artikel
70 OP 12 Visceral adipose tissue activated macrophage content and inflammatory adipokine secretion is higher in pre-eclampsia than in healthy pregnancy Huda, Shahzya
 2017
 9 C p. 14-
1 p.
 artikel
71 OP 11 Women who develop hypertensive disorders of pregnancy have altered composition of the gut microbiota at 16weeks gestation Nitert, Marloes Dekker
 2017
 9 C p. 14-
1 p.
 artikel
72 P 19 Alpha-1 microglobulin as a potential therapeutic candidate for the treatment of high blood pressure and oxidative stress in the STOX1 preeclampsia-model Hansson, Stefan
 2017
 9 C p. 45-46
2 p.
 artikel
73 P 22 Analytical evaluation of soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) on Brahms Kryptor automated immunoassay for the diagnosis of preeclampsia Chan, Siaw
 2017
 9 C p. 47-
1 p.
 artikel
74 P 36 Association of placental oxidative stress and pregnancy outcome in patients with hypertensive disorders of pregnancy – A pilot study in an Indian population Vinayagam, Vickneshwaran
 2017
 9 C p. 53-54
2 p.
 artikel
75 P 49 Brachial artery invasive versus non-invasive blood pressure monitoring in women with severe pre-eclampsia Langenegger, Eduard
 2017
 9 C p. 59-
1 p.
 artikel
76 P 50 Catechol-O-methyltransferase deficiency leads to hypersensitivity on the pressor response against angiotensin Ueki, Norikazu
 2017
 9 C p. 59-60
2 p.
 artikel
77 P 24 Cell renovation markers, apoptotic markers and placental expression of erythropoietin in preeclampsia Chulkov, Vasilii
 2017
 9 C p. 48-
1 p.
 artikel
78 P 8 Cerebral biomarkers in women developing preeclampsia Bergman, Lina
 2017
 9 C p. 40-41
2 p.
 artikel
79 P 26 Cesarean delivery in preeclamptic patients – clinical assessment focusing on coagulation. Iakovlev, Nikita
 2017
 9 C p. 49-
1 p.
 artikel
80 P 30 Clinical characteristics of patients whose preeclampsia status changes Persson, Lisa Grange
 2017
 9 C p. 50-51
2 p.
 artikel
81 P 21 Clinical utility of sFlt1/PlGF in management of hypertensive pregnancies in India Soundararajan, Revathi
 2017
 9 C p. 46-
1 p.
 artikel
82 P 27 Comparison of cardiac function parameters measured longitudinally in pregnancies with late-onset preeclampsia and normotensive pregnancies Lihme, Frederikke
 2017
 9 C p. 49-
1 p.
 artikel
83 P 1 Computational fluid dynamic simulations of maternal circulation – Wall shear stress in the human placenta and its biological implications Lecarpentier, Edouard
 2017
 9 C p. 36-37
2 p.
 artikel
84 P 16 Cross sectional study of placental growth factor in multiple pregnancy Ryan, Deirdre Hayes
 2017
 9 C p. 44-
1 p.
 artikel
85 P 39 Current research into pre-eclampsia at Royal Prince Alfred Hospital – Separate investigations into the two stages of the disorder McMaster-Fay, Roger
 2017
 9 C p. 55-
1 p.
 artikel
86 P 14 Deficiency of regulatory profile in pregnant women with early-onset preeclampsia Ribeiro, Vanessa Rocha
 2017
 9 C p. 42-43
2 p.
 artikel
87 P 4 Diagnosis, management and care of hypertensive disorders of pregnancy (HDP) in India – An Indian expert opinion Pal, Bhaskar
 2017
 9 C p. 38-39
2 p.
 artikel
88 P 41 Diagnostic biomarkers in women with CKD and superimposed pre-eclampsia Wiles, Kate
 2017
 9 C p. 55-56
2 p.
 artikel
89 P 57 Differential miR-346 and miR-582-3p expression in associations Su, Mei-Tsz
 2017
 9 C p. 62-
1 p.
 artikel
90 P 45 Does apolipoprotein B (apo B) level in early pregnancy predict excessive gestational weight gain and adverse pregnancy outcome? Bohlen, Sophia-Marie
 2017
 9 C p. 57-58
2 p.
 artikel
91 P 34 Does performance of mean arterial blood pressure for the screening of preeclampsia improve after controlling for the use of anti-hypertensive medication? Ayis, Salma
 2017
 9 C p. 52-
1 p.
 artikel
92 P 33 Does the performance of mean arterial pressure for the screening of preeclampsia differ between women with chronic hypertension and women with a history of gestational hypertension? Nzelu, Diane
 2017
 9 C p. 51-52
2 p.
 artikel
93 P 42 Down-regulation of The Nr2-regulated gene heme oxygenase-1 (HO-1) in the placenta from patients with early-onset preeclampsia Kweider, Nisreen
 2017
 9 C p. 56-57
2 p.
 artikel
94 P 2 Early fetal abdominal circumference measurement in the prediction of fetal macrosomia Alshebly, Mashael
 2017
 9 C p. 37-
1 p.
 artikel
95 P 18 Early identification of women with hellp syndrome who fail to improve after delivery and need plasma exchange Simetka, Ondrej
 2017
 9 C p. 45-
1 p.
 artikel
96 P 35 First trimester maternal serum neutrophil gelatinase-associated lipocalin (NGAL) in prediction of preeclampsia in nulliparous women Pihl, Kasper
 2017
 9 C p. 52-53
2 p.
 artikel
97 P 7 Fluid shear stress promotes placental growth factor upregulation in human syncytiotrophoblast through the camp-pka signaling pathway Lecarpentier, Edouard
 2017
 9 C p. 39-40
2 p.
 artikel
98 P 11 Hydrogen peroxide-induced inflammation and decreased vitamin D receptor in placental explants Rezeck Nunes, Priscila
 2017
 9 C p. 41-
1 p.
 artikel
99 P 51 Improvement of utero-placental and feto-placental perfusion by Pentaerythrityltetranitrate (PETN) in pregnancies with impaired uterine perfusion in mid-gestion Bowkalow, Sandy
 2017
 9 C p. 60-
1 p.
 artikel
100 P 37 Incidence and recurrence risk of low birth weight in Northern Tanzania – A Registry based study Mahande, Michael Johnson
 2017
 9 C p. 54-
1 p.
 artikel
101 P 40 Infant but not maternal APOL1 variant genotypes are associated with increased risk for preeclampsia in African Americans Davis, Robert
 2017
 9 C p. 55-
1 p.
 artikel
102 P 13 Inflammasome downregulation by silibinin and vitamin D in monocytes from pregnant women with preeclampsia Matias, Mariana Leticia
 2017
 9 C p. 42-
1 p.
 artikel
103 P 9 Involvement of B-cell lymphoma 6 in the fusion process of trophoblastic cells of the placenta Jasmer, Britta
 2017
 9 C p. 41-
1 p.
 artikel
104 P 29 Involvement of the placental neuropeptide system in preeclampsia Gharehbaghi, Daniel
 2017
 9 C p. 50-
1 p.
 artikel
105 PL 4 Cardiovascular long-term complications of preeclampsia Duvekot, Johannes
 2017
 9 C p. 2-3
2 p.
 artikel
106 P 47 Learning to evaluate and manage antenatal blood pressure at home (LEANBH) Lim, Yoke Yin
 2017
 9 C p. 58-59
2 p.
 artikel
107 PL 6 Long-term growth and neurodevelopmental outcome after early fetal growth restriction van Wassenaer-Leemhuis, Aleid G
 2017
 9 C p. 3-
1 p.
 artikel
108 PL 10 Molecular insights into placental pathophysiology in IUGR Burton, Graham J.
 2017
 9 C p. 3-
1 p.
 artikel
109 P 44 Low-density-Lipoprotein-related-proteins -1, -2, and -8 in the placenta of IUGR Lüchow, Katharina
 2017
 9 C p. 57-
1 p.
 artikel
110 P 48 Low soluble Fms-like tyrosine kinase-1, endothelin-1 and endoglin levels in women with suspected or confirmed preeclampsia, using proton pump inhibitors Saleh, Langeza
 2017
 9 C p. 59-
1 p.
 artikel
111 PL 1 Preeclampsia is not a placental disorder Thilaganathan, Baskaran
 2017
 9 C p. 2-
1 p.
 artikel
112 P 46 LXR and ABC-transporter-expression patterns in Trophoblasts in IUGR Sawierucha, Yannik
 2017
 9 C p. 58-
1 p.
 artikel
113 P 23 Maternal vascular malperfusion in spontaneous preterm birth and outcome of subsequent pregnancy Visser, Laura
 2017
 9 C p. 48-
1 p.
 artikel
114 P 15 PARROT Ireland – Placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity – A stepped wedge cluster randomised control trial Ryan, Deirdre Hayes
 2017
 9 C p. 43-
1 p.
 artikel
115 P 53 Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN-Trial) DFG GR 1955 4–1 Groten, Tanja
 2017
 9 C p. 60-61
2 p.
 artikel
116 P 52 PETN induced HO-1 expression in endothelial cells as a target for secondary prevention of endothelial dysfunction Teichert, Veronika
 2017
 9 C p. 60-
1 p.
 artikel
117 P 43 Plant sterol concentrations suggest unaffected materno-placental cholesterol supply to the fetus in IUGR Klein, Anika
 2017
 9 C p. 57-
1 p.
 artikel
118 P 28 Plasma Guanylate-Binding Protein-1 concentrations during pregnancy and preeclampsia Schuitemaker, Joost H.N.
 2017
 9 C p. 49-50
2 p.
 artikel
119 P 32 Postpartum HELLP syndrome – A case report Laskowska, Marzena
 2017
 9 C p. 51-
1 p.
 artikel
120 P 17 Pregnancy outcomes in women with previous gestational hypertension – A cohort study to guide counselling and management Nzelu, Diane
 2017
 9 C p. 44-45
2 p.
 artikel
121 P 38 Proteinase activated receptor 2 (PAR2) on blood pressure and electrolyte handling in the normal pregnant rat West, David
 2017
 9 C p. 54-55
2 p.
 artikel
122 P 3 Relationship between maternal cardiac remodeling in preeclampsia and pregnancy outcome Ilic, Aleksandra
 2017
 9 C p. 37-38
2 p.
 artikel
123 P 55 Role of uric acid and GLUT9 in pregnancy on neonatal development Gillon, Tessa
 2017
 9 C p. 61-
1 p.
 artikel
124 P 10 Stabilization of glucose concentration in the new VACUETTE® FC Mix blood collection tube for diagnosis of diabetes Griebenow, Sirid
 2017
 9 C p. 41-
1 p.
 artikel
125 P 58 The dynamics of repeated measurements of the sFlt-1/PlGF-RN ratio and the remaining pregnancy duration in patients with RN suspected preeclampsia <34weeks of gestation Klöckner, Navina
 2017
 9 C p. 62-
1 p.
 artikel
126 P 20 The expression profile of miR-517 family members in preeclamptic placenta and circulating exosome samples Biró, Orsolya
 2017
 9 C p. 46-
1 p.
 artikel
127 P 54 The identification of high risk LOH under obstetric analgesia Kumagai, Asako
 2017
 9 C p. 61-
1 p.
 artikel
128 P 5 The incidence of preeclampsia and low-dose intravenous immunoglobulin (IVIG) in recurrent abortions Varol, Füsun
 2017
 9 C p. 39-
1 p.
 artikel
129 P 56 The role of anti- and pro-inflammatory cytokines on the expression of the tolerogenic HLA class Ib molecules in relation to pregnancy and preeclampsia Persson, Gry
 2017
 9 C p. 61-62
2 p.
 artikel
130 P 31 The role of hypoxia as the driving force for nonerythroid production of globin chains in preeclamptic placentas Masoumi, Zahra
 2017
 9 C p. 51-
1 p.
 artikel
131 P 59 The sFlt-1/PlGF-ratio an remaining pregnancy duration in RN patients with suspected preeclampsia >34weeks of gestation Kreße-Chludek, Paula
 2017
 9 C p. 62-63
2 p.
 artikel
132 P 12 Treatment of very preterm preeclampsia by heparin-mediated extracorporeal LDL-Precipitation (H.E.L.P) apheresis results in favorable fetal outcome and weight gain without lowering soluble FMS-like Tyrosine Kinase-1 (sFlt-1) – The Freiburg preeclampsia HELP-Apheresis study Winkler, Karl
 2017
 9 C p. 42-
1 p.
 artikel
133 P 25 Vesicle-based resveratrol formulation for the topical treatment of Trichomonas vaginalis caused vaginal infection and inflammation Basnet, Purusotam
 2017
 9 C p. 49-
1 p.
 artikel
                             133 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland